Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Secondary or High Risk AML

Explore clinical trials studying Newly Diagnosed Secondary or High Risk AML. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Newly Diagnosed Secondary or High Risk AML trial results

Completed

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

NCT04230239

Conditions
Newly Diagnosed Secondary or High Risk AML
Locations
  • Institut Català D'Oncologia-Hospital Germans Trias I Pujol Badalona, Spain
  • Institut Català D'Oncologia - Hospital Duran I Reynals Bellvitge, Spain
  • Hospital San Pedro de Alcántara Cáceres, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
View Trial Details